ENDRA Life Sciences
NDRA
9 hedge funds and large institutions have $686K invested in ENDRA Life Sciences in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
13% more funds holding
Funds holding: 8 → 9 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
3% less capital invested
Capital invested by funds: $707K → $686K (-$21K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
+$154K |
| 2 |
IAM
ICM Asset Management
Spokane,
Washington
|
+$30.8K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$30.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$18K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
IAM
1
ICM Asset Management
Spokane,
Washington
| $300K | +$30.8K | +1 | +9% |
|
|
KJHP
2
K.J. Harrison & Partners
Toronto,
Ontario, Canada
| $126K | +$154K | +5 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $72K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $46K | – | – | – |
|
5
Citadel Advisors
Miami,
Florida
| $33K | – | – | – |
|
|
VF
6
Virtu Financial
New York
| $31K | – | – | – |
|
|
7
Northern Trust
Chicago,
Illinois
| $21K | +$30.8K | +1 | New |
|
|
BRWA
8
B. Riley Wealth Advisors
Boca Raton,
Florida
| $19K | – | – | – |
|
|
GIA
9
Gladstone Institutional Advisory
Palm Beach Gardens,
Florida
| $15K | – | – | – |
|
10
Morgan Stanley
New York
| $11K | – | – | – |
|
11
UBS Group
Zurich,
Switzerland
| $7K | – | – | – |
|
|
CB
12
CNB Bank
Clearfield,
Pennsylvania
| $4K | – | – | – |
|
13
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
|
14
Renaissance Technologies
New York
| – | -$18K | -1 | Closed |
|
|
15
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$3K | – | – |
|
NDRA Hedge Fund Activity: Q3 2020 in Review
9 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q3 2020, worth a combined $686K — down 3% from $707K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new NDRA positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was K.J. Harrison & Partners, opening a new position worth an estimated $154K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $18K sold.
- 9 institutional investors held ENDRA Life Sciences (NDRA) as of Q3 2020, up from 8 in Q2 2020.
- Funds reported $686K of ENDRA Life Sciences stock for Q3 2020, down 3% quarter-over-quarter.
- 2 funds opened new ENDRA Life Sciences positions in Q3 2020 and 1 closed out, a net change of +1 holder.
- The largest ENDRA Life Sciences buyer in Q3 2020 was K.J. Harrison & Partners, an estimated $154K added.
- The largest ENDRA Life Sciences seller in Q3 2020 was Renaissance Technologies, an estimated $18K sold.
Based on aggregated 13F filings for Q3 2020.